COLORADO SPRINGS, Colo.--(BUSINESS WIRE)-- Cannabis Science, Inc. (OTCBB: CBIS.OB - News) a pioneering US biotech company developing pharmaceutical cannabis products, is very pleased to report that two former US Attorneys, and the former head of Seattle FBI, are in favor of Washington State Initiative 502 to legalize marijuana.
On Seattle television King 5 News, two former US attorneys, John McKay and Kate Pflaumer and the former head of Seattle FBI, Charles Mandigo, spoke out on why they think it’s time to change the federal law and to legalize of marijuana.
Pflaumer stated, “It’s a policy position that has become obvious to me over 35 years working in criminal law enforcement and criminal law defense.”
Even though both US attorneys agree that it’s a bad policy, they said it was their job to enforce the law.
Former head of Seattle FBI, Charles Mandigo says he does not condone the use of marijuana, but he supports the initiative, because he feels strongly that the illegal drug trade and the resulting violence is destroying to our society.
State laws vary greatly, but under Federal law cultivation, possession, or sale of any amount, for any purpose, remain illegal. Washington State’s Initiative 502 would allow persons 21 and over to have in their possession either 1 ounce of dried marijuana, 16 ounces of marijuana infused food, or 72 ounces in a liquid form. The state’s Liquor Control Board would manage the system and the estimated income could be over $215 million per year. The state’s DUI laws would be extended to cover driving under the influence of marijuana.
Regarding concerns that the taxes being imposed would so high that this new law would not end the black market for sales, Mandigo replied, “I don’t think that’s the case, I think that most American people want to be law abiding, and given an opportunity to purchase marijuana in a regulated scheme, and not violate the law, that they would choose that as an option. Further if you are selling it under a regulated scheme, you have quality control and you know exactly what the substance is that is being sold and… at a regulated point-of-sale, that you can impose warning labels like you do for the sale of alcohol or tobacco.”